|
Shattuck Labs Inc (NASDAQ: STTK) |
|
Shattuck Labs Inc
STTK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Shattuck Labs Inc growth rates, revenue grew
by 1398.5 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 22
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.76 %
Shattuck Labs Inc net loss decreased from $-21 millions, to $-17 millions in III. Quarter 2024,
• More on STTK's Growth
|
|
Shattuck Labs Inc realized a net loss in trailing twelve months.
Shattuck Labs Inc realized cash reduction of $ -2.22 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.52.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.39.
• More on STTK's Valuation
|
|
|
|
|
Shattuck Labs Inc realized net loss in trailing twelve months.
Shattuck Labs Inc realized cash outflow of $ -2.22per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.52.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.39.
Shattuck Labs Inc Price to Book Ratio is at 0.63 lower than Industry Avg. of 91.45. and higher than S&P 500 Avg. of 0.01
• More on STTK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com